MDXX‑2
Autism Spectrum Disorder
PreclinicalActive
Key Facts
About PharmAla Biotech
Canada’s sole GMP‑grade MDMA supplier, advancing safe MDXX drug candidates for mental‑health therapeutics.
View full company profileTherapeutic Areas
Other Autism Spectrum Disorder Drugs
| Drug | Company | Phase |
|---|---|---|
| NTI164 | Neurotech International | Phase 3 |
| Exo‑Autism | Advancells | Phase 1 |
| Autism Program | Ignite Biomedical | Discovery |
| Kingdom Therapeutics Collaboration | Celadon Pharmaceuticals | Pre-clinical |
| NeuroNOS-1 | NeuroNOS | Preclinical |
| Banked Cord Blood Stem Cells | Cryo-Cell | Clinical Trials |